Changes in soft tissue body composition and plasma lipid metabolism during nandrolone decanoate therapy in postmenopausal osteoporotic women
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 38 (3), 238-242
- https://doi.org/10.1016/0026-0495(89)90081-4
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?Bone and Mineral, 1989
- Measurement of the subcutaneous fat in the distal forearm by single photon absorptiometryMetabolism, 1989
- Measurement of lean body mass and total body fat using dual photon absorptiometryMetabolism, 1986
- EPIDEMIOLOGY OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURESEpidemiologic Reviews, 1985
- Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of actionMetabolism, 1983
- Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal femalesEuropean Journal of Clinical Investigation, 1980
- Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral massMetabolism, 1977
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976
- RELATION BETWEEN BONE MASS AND MUSCLE WEIGHTThe Lancet, 1970
- A COMPARATIVE STUDY OF THE METABOLIC EFFECTS OF TESTOSTERONE PROPIONATE IN NORMAL MEN AND WOMEN AND IN EUNUCHOIDISM1,2Endocrinology, 1940